Cellectis (CLLS) EPS (Basic) (2015 - 2026)

Cellectis' (CLLS) quarterly EPS (Basic) came in at -$0.0 in Q1 2026, little changed year-on-year from -$0.0 in Q1 2025, and up 30.94% quarter-over-quarter from -$0.0 in Q4 2025.

Cellectis (CLLS) EPS (Basic) (2015 - 2026) Analysis & Trends

Cellectis' EPS (Basic) history runs 12 years deep, the most recent figure standing at -$0.0 for Q1 2026.

  • On a quarterly basis, EPS (Basic) changed 0.37% year-over-year to -$0.0 in Q1 2026; TTM through Mar 2026 was -$0.23, a 45.61% increase from a year earlier, with the FY2025 full-year figure at -$0.0, up 100.0% from the prior year.
  • EPS (Basic) advanced to -$0.0 in Q1 2026 per CLLS's latest filing, from -$0.0 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.08 in Q1 2024 and bottomed at -$0.76 in Q1 2022.
  • The 5-year median for EPS (Basic) is -$0.26 (2024), against an average of -$0.29.
  • Across the five-year window, EPS (Basic) sank 137.63% in 2022 and soared 113.44% in 2024, its largest moves.
  • Year by year, EPS (Basic) stood at -$0.59 in 2022, then fell by 24.52% to -$0.73 in 2023, then surged by 108.92% to $0.07 in 2024, then sank by 100.0% to -$0.0 in 2025, then jumped by 30.94% to -$0.0 in 2026.
  • Per Business Quant, the three latest CLLS EPS (Basic) figures stand at -$0.0 (Q1 2026), -$0.0 (Q4 2025), and $0.01 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Cellectis 285.50 Mn 99.83 Mn - 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.01
Jun 30, 2025 -0.24
Mar 31, 2025 0.00
Dec 31, 2024 0.07
Sep 30, 2024 -0.26
Jun 30, 2024 -0.31
Mar 31, 2024 0.08
Dec 31, 2023 -0.73
Sep 30, 2023 -0.31
Jun 30, 2023 -0.22
Mar 31, 2023 -0.58
Dec 31, 2022 -0.59
Sep 30, 2022 -0.63
Jun 30, 2022 -0.42
Mar 31, 2022 -0.76
Dec 31, 2021 -0.56
Sep 30, 2021 -0.82
Jun 30, 2021 -0.88